Steven C Rose
Overview
Explore the profile of Steven C Rose including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
64
Citations
1410
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Srinivas S, Pianka K, Rockwell H, Yeluru A, Liau J, Ganesh A, et al.
Cardiovasc Intervent Radiol
. 2025 Mar;
PMID: 40064654
Purpose: To evaluate the relationship between radioembolization tumor dose and imaging response for hepatocellular carcinoma (HCC) treated with radioembolization. Materials And Methods: Retrospective single-institution evaluation of treatment-naïve patients with HCC...
2.
Pianka K, Barahman M, Minocha J, Redmond J, Schnickel G, Rose S, et al.
Eur J Nucl Med Mol Imaging
. 2024 Jun;
51(12):3744-3752.
PMID: 38913189
Purpose: The transarterial radioembolization (TARE) dose is traditionally calculated using the single-compartment Medical Internal Radiation Dose (MIRD) formula. This study utilized voxel-based dosimetry to correlate tumor dose with explant pathology...
3.
Moon A, Kim H, Singal A, Owen D, Mendiratta-Lala M, Parikh N, et al.
Hepatol Commun
. 2023 Jun;
7(7).
PMID: 37314737
Background Aims: Early-stage HCC can be treated with thermal ablation or stereotactic body radiation therapy (SBRT). We retrospectively compared local progression, mortality, and toxicity among patients with HCC treated with...
4.
Srinivas S, Rose S, Al Jammal O, Hsieh L, Rockwell H, Duncan D, et al.
Cardiovasc Intervent Radiol
. 2023 Mar;
46(4):460-469.
PMID: 36854903
Purpose: To assess the tumor response rates and liver toxicity of boosted-dose transarterial radioembolization (TARE) for treatment of hepatocellular carcinoma (HCC) refractory to previous transarterial embolization (TAE) and/or chemoembolization (TACE)....
5.
Liu M, Rose S, Loh A, Taddonio M, Redmond J, Meisinger Q, et al.
Cardiovasc Intervent Radiol
. 2022 Apr;
45(6):834-840.
PMID: 35441243
Purpose: To describe the technique and document utility of adjunctive cone-beam CT (CBCT) in patients undergoing bronchial artery embolization (BAE) or chemoinfusion (BAC). Materials And Methods: Between August 2010 and...
6.
Rose S, Berman Z, Fischman A, Young L, Flanagan S, Katz M, et al.
J Vasc Interv Radiol
. 2020 May;
31(6):986-992.
PMID: 32414569
Purpose: To assess the feasibility, safety, and efficacy of balloon-assisted delivery of ethylene vinyl alcohol copolymer (EVOH) for a range of peripheral arterial applications. Materials And Methods: Six academic medical...
7.
8.
Rose S, Narsinh K, Isaacson A, Fischman A, Golzarian J
AJR Am J Roentgenol
. 2018 Dec;
212(3):686-695.
PMID: 30589385
Objective: Particulate emboli are passive agents that follow blood flow. Deployed antireflux devices obstruct blood flow. Conclusion: The aim of this review is to describe the complex hemodynamic alterations to...
9.
Kennedy A, Cohn M, Coldwell D, Drooz A, Ehrenwald E, Kaiser A, et al.
J Gastrointest Oncol
. 2018 May;
9(2):E13-E14.
PMID: 29755783
[This corrects the article DOI: 10.21037/jgo.2017.03.10.].
10.
Devulapalli K, Fidelman N, Soulen M, Miller M, Johnson M, Addo E, et al.
Radiology
. 2018 May;
288(3):774-781.
PMID: 29737954
Purpose To determine the frequency of hepatobiliary infections after transarterial radioembolization (TARE) with yttrium 90 (Y) in patients with liver malignancy and a history of biliary intervention. Materials and Methods...